Skip to content

Early Access to ART for All in Swaziland: Effects on Economic Outcomes

MaxART: The Effect of Early Access to ART for All in Swaziland on Economic Outcomes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03789448
Enrollment
3019
Registered
2018-12-28
Start date
2014-09-01
Completion date
2017-08-31
Last updated
2019-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Keywords

Antiretroviral Treatment

Brief summary

The purpose of this study is to evaluate the impact of offering early antiretroviral therapy to HIV-positive individuals in government-managed health facilities in Swaziland on a range of economic outcomes

Detailed description

The MaxART study is a three-year stepped-wedge randomized trial with open enrollment for all adults 18 years and older across 14 rural health facilities in Swaziland's Hhohho Region. The main trial registration is accessible at: https://clinicaltrials.gov/ct2/show/record/NCT02909218. This registration is specific to the economic evaluation of the MaxART study which aims to quantify the causal impacts of early ART initiation (compared to national standard care) on a range of key economic outcomes, including healthcare expenditures, productivity, and household wealth.

Interventions

All HIV-positive individuals will be initiated on Swaziland's recommended first-line ART regimen, unless contraindicated when recommended alternate regimens will be used per national guidelines

Sponsors

Clinton Health Access Initiative Inc.
CollaboratorOTHER
Till Bärnighausen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All HIV-positive individuals who are aged 18 years or older, are ART naïve and attend the health facilities included in the study

Exclusion criteria

* All HIV-positive individuals who are \<18 years of age * All HIV-positive pregnant or breastfeeding women * All HIV-positive individuals who did not consent to participate

Design outcomes

Primary

MeasureTime frameDescription
Total healthcare expenditures (for hospitalization and primary care)12 monthsIncluding direct health care costs (e.g., surgery, medication, consultation) and indirect costs (e.g., transport to clinic, payment for someone to look after children, salary lost for time off...)
Total productivity hours24 hoursTotal Hours per day spent on income generation activities

Secondary

MeasureTime frameDescription
Rate of participants with current employmentAt study completion, an average of 1.5 yearsEmployment rate among participants, including full-time and part-time salary work
Total sum of self-reported monthly expenditures of the participant's household12 monthsIncluding food and non-food items (e.g., electricity, water, transport, personal care items, insurance, festivals, etc.)
Household Assets Ownership and Living Standards IndexAt study completion, an average of 1.5 yearsAggregated index based on ownership of assets (e.g., refrigerator, TV, table, phone...) and living standards (e.g., flush toilet, cooking facilites, floor/wall/roof material...), total scale score is determined via principal component analysis and averaged around 0

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026